Quotables
"Rail travel at high speeds is not possible because passengers, unable to breathe, would die of asphyxia."
Dionysius Lardner, Professor of Natural Philosophy and Astronomy at University College, London ; 1830
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7413816 | Organic metallic complex and electroluminescent element using the same A white or whitish luminescent material for phosphorescence is provided by synthesizing an organometallic complex that is able to convert a triplet excited state into light emission. In particular, a white electroluminescent device that has a high luminous efficienc... | 08/19/2008 |
| 7268095 | Transition metal catalysts for (co) polymerizing of olefinic monomers A compound of the formula Ia or Ib; where, in the formula Ia, E1 is O, S, Se, Te, NR, CR2, or PR; E2, E... | 09/11/2007 |
| 7176307 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex Organometal complexes which are obtainable with a good yield by using a ligand which can be easily synthesized are provided. The organometal complexes are excellent in heat resistance. An electroluminescence element having high light emission efficiency is manufactu... | 02/13/2007 |
| 7109343 | Metal catalysts and methods for making and using same Compounds having the formula: are disclosed. M1 and M2 are the same or different and are transition metal atoms or ions; Z2 and Z3, independently, are the atoms necessa... | 09/19/2006 |
| 7087548 | Preparation and use of a heterogeneous rhodium catalyst for the hydrogenation of a double bond of an α-β-unsaturated carbonyl compound A process for preparing an Rh-based catalytic system heterogenized on an organic or mineral support, characterized in that: a) a rhodium derivative with a valency state>0 is reduced in an ether or aromatic solvent and in the presence of a compound chosen from the gr... | 08/08/2006 |
| 7081472 | Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them Metal-complexable substituted bis-indole derivatives comprising the structure shown in formula (I) hereunder: enantiomers and pharmaceutically acceptable salts thereof and metal complexes thereof, wherein L, R1, R2, R3, C1... | 07/25/2006 |
| 7078114 | Phosphorescence compound and electro field light emitting device having the same A phosphorescent compound is formed by synthesizing an orthometallated complex by using easily-synthesized ligands. An electroluminescent device having high luminous efficiency uses the phosphorescent compound. Moreover, a light-emitting device operating at a low vo... | 07/18/2006 |
| 7041390 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex Organometal complexes which are obtainable with a good yield by using a ligand which can be easily synthesized are provided. The organometal complexes are excellent in heat resistance. An electroluminescence element having high light emission efficiency is manufactu... | 05/09/2006 |
| 7030051 | Dirhodium catalyst compositions and methods for using same Disclosed is method for increasing the efficiency of a dirhodium catalyst. The method includes providing a dirhodium catalyst, providing an organic ester, and contacting the dirhodium catalyst and the organic ester under conditions effective to increase the efficien... | 04/18/2006 |
| 6998491 | Catalyst comprising a cyclic imide compound A catalyst includes a cyclic imide compound having an N-substituted cyclic imide skeleton represented by following Formula (I): wherein X is an oxygen atom or a hydroxyl group, and having a solubility parameter of less ... | 02/14/2006 |
| RE38947 | Method of enantioselectively catalyzing a reaction A chiral catalyst is disclosed together with methods of using it for enantioselective syntheses. The chiral catalyst includes a nucleus with two metal atoms that has four bridging ligands oriented radially to the axis of the nucleus. Each of these ligands includes a... | 01/24/2006 |
| 6962891 | Solid support dirhodium catalyst compositions and methods for making and using same Disclosed are dirhodium catalyst compositions. One such dirhodium catalyst composition includes a dirhodium catalyst and a solid support. The dirhodium catalyst includes a Rh—Rh moiety and four bridging ligand moieties. The dirhodium catalyst and the solid support... | 11/08/2005 |
| 6762304 | Metal catalysts and methods for making and using same Compounds having the formula: are disclosed. M1 and M2 are the same or different and are transition metal atoms or ions; Z2 and Z3, independently, are the atoms necessary to co... | 07/13/2004 |
| 6608100 | HIV protease inhibitors based on amino acid derivatives A compound selected from the group consisting of a compound of formula I ##STR1## a compound of formula II ##STR2## and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1 | 08/19/2003 |
| 6525086 | Compounds, their preparation and use The present invention relates to compounds of formula (I) ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, A, X, T, Q, Z, U, Y, Ar, p and n are as defined in the speci... | 02/25/2003 |
| 6410746 | Metal cataltsts and methods for making and using same Compounds having the formula: ##STR1## are disclosed. M1 and M2 are the same or different and are transition metal atoms or ions; Z2 and Z3, independently, are the atoms necessary to complete a 3-12 membered het... | 06/25/2002 |
| 6337064 | Manganese chelates with high relaxivity in serum Compounds of formula (I) both in the racemic and optically active forms, are used in MRI diagnostic imaging. ##STR1##... | 01/08/2002 |
| 6326493 | Metallocene compounds, processes for the preparation thereof, catalyst components for olefin polymerization, and processes for the production of olefin polymers A metallocene compound is provided wherein to a transition metal compound is bonded a multidentate compound wherein a substituted cycloalkadienyl ring CA1 having therein a heteroaromatic group Ra containing an oxygen, sulfur or nitrogen atom on... | 12/04/2001 |
| 6169051 | Metallocene compounds, processes for the preparation thereof, catalyst components for olefin polymerization, and processes for the production of olefin polymers A metallocene compound is provided wherein to a transition metal compound is bonded a multidentate compound wherein a substituted cycloalkadienyl ring CA1 having therein a heteroaromatic group Ra containing an oxygen, sulfur or nitrogen atom on... | 01/02/2001 |
| 6136960 | Method for evaluation of the ratio of amounts of biomolecules or their sub-populations in a mixture The present invention is directed to a method of determining the ratio of the concentration or amounts of two or more chemical compounds and/or biopolymers, or of the relative amounts of sub-populations of closely structurally related compounds, in a mult... | 10/24/2000 |
| 6090950 | Chiral hydride complexes Novel chiral boron and aluminum hydride complexes, compositions comprising the chiral hydride complexes, and methods for their synthesis and use are described. The novel chiral hydride complexes are of the formulas: MBH4-n-a (R*)n (R') | 07/18/2000 |
| 6001872 | Water soluble transplatinum complexes with anti-cancer activity and method of using same The present invention relates to the treatment of tumors with a novel water soluble trans-platinum coordination compound having the general structural formula [PtBXm (NR*3)] where B is a planar, heterocyclic ring containing at least ... | 12/14/1999 |
| 5927283 | Allosteric modifiers of hemoglobin A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in a wide variety of treatments including hypoxia, hypothermia, ischemia, stroke, ARDS, COPD, surgic... | 07/27/1999 |
| 5705521 | Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in radiation oncology applications. The compounds are capable of acting on hemoglobin in whole blood... | 01/06/1998 |
| 5703258 | Silicon and phosphorus containing compositions A flame retardant organic silicon and phosphorus containing compound is produced by reacting a silicon halides compound with an organic phosphorus compound to produce an organic silicon and phosphorus halides compound which is then reacted with an organic... | 12/30/1997 |
| 5693310 | Amide complexes Compounds of general Formula I ##STR1## wherein R3 is a saturated, unsaturated, straight- or branched-chain or cyclic aliphatic hydrocarbon residue of up to 16 carbon atoms or, if R4 is a hydrogen atom, a cycloalkyl group or an ... | 12/02/1997 |
| 5691436 | Production of silicon-phosphorus containing compositions A mixture of silicon and phosphorus are heated and reacted with halide to produce silicon tetrahalides, silicon-phosphorus halide and phosphorus trihalides compositions. These compositions are reacted with any suitable organic, inorganic-organic and/or in... | 11/25/1997 |
| 5681975 | Single source metalloorgranic precursors to type 14-16 semiconductors The present invention relates to a single source metalloorganic precursor compound of the formula: (2-NR-Q-)l M-Am (I=0-4, m=0-4, l+m=2 or 4) wherein M is selected form the Group 14 elements of Germanium, Tin or Lead; A and R are independently... | 10/28/1997 |
| 5677330 | Medical uses of allosteric hemoglobin modifier compounds in patient care A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in a wide variety of treatments including hypoxia, hypothermia, ischemia, stroke, ARDS, COPD, surgic... | 10/14/1997 |
| 5648375 | Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers Allosteric hemoglobin modifier compound activity on p50 is potentiated by using the compound in combination with a hydrophobic compound such as an anesthetic.... | 07/15/1997 |
| 5591854 | Enantioselective synthesis of seven-membered carbocycles and tropanes A process of enantioselective synthesis of seven-membered carbocycles in the presence of di-rhodium(II) tetracarboxylate catalysts.... | 01/07/1997 |
| 5527909 | Single source metalloorganic precursors to type II-VI semiconductors The present invention relates a precursor metal organic compound of the formula: 2-NR-Q-M-A wherein M is selected from the Group IIb elements of Zinc, Cadmium, of Mercury; A is selected from R: Amide, alkyl having from 1 to 20 carbon atoms, aryl, substitu... | 06/18/1996 |
| 5527905 | Anti-tumor platinum complexes, their preparation and their therapeutic use Compounds of formula (I): ##STR1## in which: A and B are separately monoamines or together diamines; and Z is a group of formula (II) or (III): ##STR2## (in which R1, R2 and R7 are various organic groups, n is 0,... | 06/18/1996 |
| 5506253 | Composition, process and use A compound of the general formula ##STR1## or a salt or complex thereof, in which X, Y and Z are all optionally substituted carbon atoms and R is hydrogen, optionally substituted hydrocarbyl or acyl or --COOR7 and R7 is hydrocar... | 04/09/1996 |
| 5432191 | Allosteric hemoglobin modifiers to decrease oxygen affinity in blood A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood dur... | 07/11/1995 |
| 5393750 | Composition, process and use A compound of the general formula ##STR1## or a salt or complex thereof, in which X, Y and Z are all optionally substituted carbon atoms and R is hydrogen, optionally substituted hydrocarbyl or acyl or --COOR7 and R7 is hydrocar... | 02/28/1995 |
| 5290803 | Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood dur... | 03/01/1994 |
| 5283339 | Immobilized metal aqueous two-phase extraction and precipitation Metallated compounds can be used to extract or precipitate proteins from solution. The compounds can be polymers, such as polyalkylene glycols, which can be mono- or bimetallated or smaller bis-metal chelates, such as ethylenebis(oxyethylenenitrilo)tetraa... | 02/01/1994 |
| 5250701 | Allosteric hemoglobin modifiers which decrease oxygen affinity in blood A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood dur... | 10/05/1993 |
| 5238955 | Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkylethylenediamines Antitumor acting platinum(II or IV) complexes of the general formula ##STR1## where B represents a phenyl-C1 -C4 -alkyl radical which is optionally substituted in the phenyl nucleus by the radical R1 and R1... | 08/24/1993 |
